Patent · US Active

Crystalline solids of a metAP-2 inhibitor and methods of making and using same

US9827221B2 · kind B2 · utility

0Cited by
33References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 3, 2016
Grant dateNov 28, 2017
Priority date—
Expiry dateMay 3, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D407/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The disclosure is in part directed to crystalline forms of 6-O-(4-dimethylaminoethoxy)cinnamoyl fumagillol and variants thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.